| KOMISJA NADZORU FINANSOWEGO | ||||||||||||
| Raport bieżący nr | 10 | / | 2022 | |||||||||
| Data sporządzenia: | 2022-08-04 | |||||||||||
| Skrócona nazwa emitenta | ||||||||||||
| MILESTONE MEDICAL | ||||||||||||
| Temat | ||||||||||||
| Signing the distribution agreement with Clinical Technology, Inc. for the CompuFlo® Epidural System | ||||||||||||
| Podstawa prawna | ||||||||||||
| Art. 17 ust. 1 MAR - informacje poufne. | ||||||||||||
| Treść raportu: | ||||||||||||
| The Board of Directors of Milestone Medical Inc. (WAR: MMD, "the Company", "the Issuer"), today announced that it has re-engaged Clinical Technology, Inc. (CTI), a leading specialty distributor of medical products in the mid-west and east coast regions of the United States, as a domestic distributor for the CompuFlo® Epidural System. The Board of Directors of the Company is very pleased to re-engage the partnership with CTI. CTI is a partner bringing a sizable mid-west and east coast sales force, extensive relationships with physicians, pain clinics and hospitals, as well as a proven track record of introducing new medical devices. The Board of Directors of the Company believes that the collaboration with CTI to advance the commercial rollout of the CompuFlo Epidural System is a critical step towards providing a modern and safer solution to pain management for both hospitals, and now, private pain clinics. | ||||||||||||
| MESSAGE (ENGLISH VERSION) | |||
| (pełna nazwa emitenta) | ||||||||||||||||
| (skrócona nazwa emitenta) | (sektor wg. klasyfikacji GPW w W-wie) | |||||||||||||||
| (kod pocztowy) | (miejscowość) | |||||||||||||||
| (ulica) | (numer) | |||||||||||||||
| (telefon) | (fax) | |||||||||||||||
| (e-mail) | (www) | |||||||||||||||
| (NIP) | (REGON) | |||||||||||||||
| PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ | |||||
| Data | Imię i Nazwisko | Stanowisko/Funkcja | Podpis | ||
| 2022-08-04 | Keisha Harcum | Controller | Keisha Harcum | ||
